Meeting
2023 ASCO Genitourinary Cancers Symposium
Prediction of early prostate cancer recurrence using a liquid biopsy approach.
Authors
Kambiz Rahbar
University Hospital Muenster, Muenster, Germany
Kambiz Rahbar , Mark Kidd , Konstantin Egon Seitzer , Andres Jan Schrader , Martin Boegemann , Irvin Mark Modlin
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Prostate Cancer
Track
Prostate Cancer - Advanced,Prostate Cancer - Localized
Sub Track
Translational Research, Tumor Biology, Biomarkers, and Pathology
Citation
J Clin Oncol 41, 2023 (suppl 6; abstr 386)
DOI
10.1200/JCO.2023.41.6_suppl.386
Abstract #
386
Poster Bd #
P3
Abstract Disclosures
Similar Posters
Poster
2017 Genitourinary Cancers Symposium
Validation of GEMCaP as a DNA based biomarker to predict disease recurrence in patients undergoing prostatectomy for prostate cancer.
First Author: Hao Gia Nguyen
Poster
2016 Genitourinary Cancers Symposium
Phosphodiesterase type 5 inhibitors (PDE5i) and prostate cancer recurrence.
First Author: Stacy Loeb
Poster
2023 ASCO Genitourinary Cancers Symposium
Early biochemical outcomes following PSMA-guided approach for biochemical relapse after prostatectomy: PSICHE trial.
First Author: Giulio Francolini
Poster
2023 ASCO Genitourinary Cancers Symposium
Patterns of failure with 18F-DCFPyL PSMA PET/CT in the post-prostatectomy setting: A regional cohort analysis.
First Author: Samantha S. Sigurdson